Literature DB >> 11049787

Acute onset of type I diabetes mellitus after severe echovirus 9 infection: putative pathogenic pathways.

G R Vreugdenhil1, N C Schloot, A Hoorens, C Rongen, D G Pipeleers, W J Melchers, B O Roep, J M Galama.   

Abstract

Enterovirus infections have been implicated in the development of type I diabetes mellitus. They may cause beta cell destruction either by cytolytic infection in the pancreas or indirectly by contributing to autoimmune reactivity. We sought evidence for these 2 mechanisms in a case of acute-onset diabetes mellitus that occurred during severe echovirus 9 infection. The virus was isolated and administered to cultured human beta cells. No viral proliferation was observed, and no beta cell death was induced, while parallel exposure to Coxsackie B virus serotype 3 resulted in viral proliferation and massive beta cell death. Although the viral protein 2C exhibited a sequence similar to that of the beta cell autoantigen glutamic acid decarboxylase (GAD(65)), no cross-reactive T cell responses were detected. The patient did not develop antibodies to GAD(65) either. Absence of evidence for direct cytolytic action or an indirect effect through molecular mimicry with GAD(65) in the present case raises the possibility of another indirect pathway through which enteroviruses can cause diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11049787     DOI: 10.1086/318159

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  17 in total

1.  Viruses and diabetes: is there something sweet about hepatitis C infection?

Authors:  A L Mason; G J Alexander
Journal:  Ochsner J       Date:  2001-07

2.  Pathogenesis of fulminant type 1 diabetes.

Authors:  Akihisa Imagawa; Toshiaki Hanafusa
Journal:  Rev Diabet Stud       Date:  2007-02-10

Review 3.  Enterovirus and type 1 diabetes: What is the matter?

Authors:  Carla Sanchez Bergamin; Sergio Atala Dib
Journal:  World J Diabetes       Date:  2015-06-25

Review 4.  The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure.

Authors:  Bart O Roep
Journal:  Diabetologia       Date:  2003-03-22       Impact factor: 10.122

5.  High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes.

Authors:  A Imagawa; T Hanafusa; H Makino; J-I Miyagawa; P Juto
Journal:  Diabetologia       Date:  2005-01-15       Impact factor: 10.122

6.  A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models.

Authors:  Pär G Larsson; Tadepally Lakshmikanth; Olli H Laitinen; Renata Utorova; Stella Jacobson; Maarit Oikarinen; Erna Domsgen; Minni R L Koivunen; Pascal Chaux; Nicolas Devard; Valerie Lecouturier; Jeffrey Almond; Mikael Knip; Heikki Hyöty; Malin Flodström-Tullberg
Journal:  Diabetologia       Date:  2014-11-05       Impact factor: 10.122

7.  T lymphocyte response against pancreatic beta cell antigens in fulminant Type 1 diabetes.

Authors:  R Kotani; M Nagata; A Imagawa; H Moriyama; H Yasuda; J Miyagawa; T Hanafusa; K Yokono
Journal:  Diabetologia       Date:  2004-07-09       Impact factor: 10.122

8.  Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells.

Authors:  P Ylipaasto; K Klingel; A M Lindberg; T Otonkoski; R Kandolf; T Hovi; M Roivainen
Journal:  Diabetologia       Date:  2004-01-15       Impact factor: 10.122

9.  Type 1 diabetes islet associated antibodies in subjects infected by echovirus 16.

Authors:  E Cabrera-Rode; L Sarmiento; C Tiberti; G Molina; J Barrios; D Hernández; O Díaz-Horta; U Di Mario
Journal:  Diabetologia       Date:  2003-07-29       Impact factor: 10.122

10.  Enterovirus-induced gene expression profile is critical for human pancreatic islet destruction.

Authors:  P Ylipaasto; T Smura; P Gopalacharyulu; A Paananen; T Seppänen-Laakso; S Kaijalainen; H Ahlfors; O Korsgren; J R T Lakey; R Lahesmaa; L Piemonti; M Oresic; J Galama; M Roivainen
Journal:  Diabetologia       Date:  2012-09-16       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.